SynthesisFrontiers in oncology2021

A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Xiaochen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.